InfuSystem (NYSE: INFU) schedules Q2 2026 results release and investor call
Rhea-AI Filing Summary
InfuSystem Holdings, Inc. announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026 before the market opens. Management will host a conference call for investors the same day at 9:00 a.m. Eastern Time, accessible by telephone and live webcast through the company’s investor relations website. A telephone and web replay will be available through Wednesday, November 4, 2026. InfuSystem describes itself as a leading national health care service provider operating two platforms: Patient Services and Device Solutions.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Results release date: August 4, 2026
Conference call time: 9:00 a.m. Eastern Time
Replay access code: 6164241
+2 more
5 metrics
Results release date
August 4, 2026
Date second quarter 2026 financial results will be issued
Conference call time
9:00 a.m. Eastern Time
Time of the Q2 2026 investor conference call on August 4, 2026
Replay access code
6164241
Telephone replay access code for the Q2 2026 conference call
Replay end date
Wednesday, November 4, 2026
Last day the Q2 2026 call replay is available
Headquarters locations
Michigan, Kansas, California, Massachusetts, Texas, Ontario (Canada)
States and province where Centers of Excellence are operated
Key Terms
Regulation FD Disclosure, durable medical equipment, Centers of Excellence, direct payer rentals
4 terms
Regulation FD Disclosure regulatory
"The information furnished in this Item 7.01 — “Regulation FD Disclosure”"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
durable medical equipment medical
"facilitating outpatient care for durable medical equipment manufacturers"
Durable medical equipment (DME) includes long-lasting devices used to help people manage health conditions and improve mobility, such as wheelchairs, hospital beds, and oxygen machines. These items are designed to be reused and are often covered by health insurance. For investors, DME represents a steady market because demand remains consistent as populations age and healthcare needs grow.
Centers of Excellence technical
"operates Centers of Excellence in Michigan, Kansas, California"
Centers of excellence are specialized teams or departments within an organization that focus on developing and applying expert knowledge or skills in a particular area. They serve as hubs for best practices, innovation, and high-quality performance, much like a master chef’s kitchen dedicated to perfecting a specific cuisine. For investors, these centers can signal a company’s commitment to excellence and innovation, potentially influencing its long-term success and stability.
direct payer rentals financial
"Device Solutions segment is comprised of direct payer rentals"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
When will InfuSystem (INFU) report its second quarter 2026 results?
InfuSystem will report its second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens. The company will discuss these results on an investor conference call later that morning at 9:00 a.m. Eastern Time.
What time is InfuSystem (INFU)'s Q2 2026 investor conference call?
The InfuSystem Q2 2026 investor conference call is scheduled for 9:00 a.m. Eastern Time on August 4, 2026. Investors can join by dialing the listed U.S. numbers or by accessing a live webcast via the company’s investor relations website.
How can investors access the InfuSystem (INFU) Q2 2026 earnings webcast?
Investors can access the InfuSystem Q2 2026 webcast via a live stream in the Investors section at https://ir.infusystem.com/. Telephone access is also available using the provided domestic and international dial-in numbers on the same date and time.
How long will the InfuSystem (INFU) Q2 2026 call replay be available?
The replay of InfuSystem’s Q2 2026 conference call will be available through Wednesday, November 4, 2026. Investors can listen via the investor relations website or by phone using replay access code 6164241 and the listed replay numbers.
What businesses are in InfuSystem (INFU)'s Patient Services segment?
InfuSystem’s Patient Services segment includes Oncology, Pain Management, and Wound Therapy businesses. This platform focuses on last-mile clinic-to-home healthcare where continuing treatment involves complex durable medical equipment and associated services for patients.
What does the Device Solutions segment of InfuSystem (INFU) provide?
InfuSystem’s Device Solutions segment provides direct payer rentals, pump and consumable sales, and biomedical services and repair. This platform supports Patient Services and leverages the company’s service orientation to win incremental business from direct payer clients.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 28, 2026
___________________________________
(Exact name of registrant as specified in its charter)
___________________________________
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
(Address of principal executive offices) (Zip Code) | ||||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
Not Applicable | ||||||||
(Former Name or Former Address, if Changed Since Last Report) | ||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 - Regulation FD
On July 28, 2026 , InfuSystem Holdings, Inc. (the “Company”) issued a press release announcing that the Company will disclose its financial results for the second quarter 2026 on Tuesday, August 4, 2026 before the market opens. The Company will also conduct a conference call for all interested investors on Tuesday, August 4, 2026 at 9:00 a.m. Eastern Time. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information furnished in this Item 7.01 — “Regulation FD Disclosure” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 9.01 - Financial Statements and Exhibits
(d) Exhibits
Exhibit No. | Description | |||||||
99.1 | Press Release of InfuSystem Holdings, Inc. dated July 28, 2026 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INFUSYSTEM HOLDINGS, INC. | |||||
By: | /s/ Carrie Lachance | ||||
Carrie Lachance | |||||
Chief Executive Officer and Director | |||||
Dated: July 28, 2026
Exhibit 99.1
 | InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 | ||||
FOR IMMEDIATE RELEASE
CONTACT: Barry Steele
Chief Financial Officer
248-260-2211
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
Investor Conference Call to be held 9:00 a.m. Eastern Time
Rochester Hills, Michigan, July 28, 2026 — InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens.
The Company will also conduct a conference call for all interested parties on Tuesday, August 4, 2026 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ or by calling (855) 669-9658 or (412) 317-0088, replay access code 6164241 through Wednesday, November 4, 2026.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
####